Hypertrophic pachymeningitis with MPO-ANCA-positive vasculitis

Clinical Rheumatology

Volumn 29, Issue 1, 2010, Pages 111-113

  Horino, Taro ^a   Takao, Toshihiro ^a   Taniguchi, Yoshinori ^a   Terada, Yoshio ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Hypertrophic pachymeningitis (HP); Myeloperoxidase antineutrophil cytoplasmic antibody (MPO ANCA); Wegener's granulomatosis (WG)

Indexed keywords

C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; GADOLINIUM; GLUCOSE; HEMOGLOBIN; INTERLEUKIN 6; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

AGED; ANCA ASSOCIATED VASCULITIS; ANTIBODY TITER; ARTICLE; BRAIN EDEMA; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID PRESSURE; CONTRAST ENHANCEMENT; DIPLOPIA; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG WITHDRAWAL; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; FACIAL NERVE PARALYSIS; FEVER; FOLLOW UP; HEADACHE; HEARING LOSS; HEMIPARESIS; HUMAN; HYPERTROPHIC PACHYMENINGITIS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALAISE; MALE; MYALGIA; NEUTROPHIL COUNT; PARAMENINGEAL DISORDER; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; REMISSION; SPEECH DISORDER; THROMBOCYTE COUNT; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; DURA MATER; HEADACHE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MENINGITIS; METHYLPREDNISOLONE; PEROXIDASE; PREDNISOLONE; PULSE THERAPY, DRUG; VASCULITIS;

EID: 72949083309     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1269-x     Document Type: Article

References (8)

1. + T lymphocytes infiltrate predominantly in the inflammatory foci of MPO-ANCA-positive thoracic hypertrophic pachymeningitis in a patient with HLA-A24 Mod Rheumatol 17 75 80
2. MJ Kupersmith V Martin G Heller, et al. 2004 Idiopathic hypertrophic pachymeningitis Neurology 62 686 694
3. T Nagashima S Maguchi Y Terayama, et al. 2000 P-ANCA-positive Wegener's granulomatosis presenting with hypertrophic pachymeningitis and multiple cranial neuropathies: case report and review of literature Neuropathology 1 23 30
4. N Martin C Masson D Henin, et al. 1989 Hypertrophic cranial pachymeningitis. Assessment with CT and MR imaging Am J Neuroradiol 10 477 484
5. CG Kallenberg E Brouwer JJ Weening, et al. 1994 Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential Kidney Int 46 1 15
6. NJ Newman TL Slamovits S Friedland, et al. 1995 Neuro-ophthalmic manifestations of meningocerebral inflammation from the limited form of Wegener's granulomatosis Am J Ophthalmol 120 613 621
7. GS Hoffman GS Kerr RY Leavitt, et al. 1992 Wegener granulomatosis: an analysis of 158 patients Ann Intern Med 116 488 498
8. Y Hayashi H Sugawara M Otsuka, et al. 2008 Fatal hemoperitoneum preceded by cranial hypertrophic pachymeningitis in a patient with ANCA-positive microscopic polyangitis Intern Med 47 1061 1063